Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-30.74M -41.71M -49.23M -59.6M -66.71M -70.09M -68.17M -62.77M -62.77M -66.14M -68.77M -51.87M -49.05M -41.24M -34.12M -62.96M -54.67M -47.03M
Depreciation & Amortization
353K 358K 490K 706K 858K 1.01M 1.02M 925K 896K 802K 751K 704K 70K 635K 544K 456K 485K 315K
Stock-Based Compensation
3.38M 4.2M 5.29M 6.05M 7.03M 7.63M 7.63M 7.74M 7.55M 7.63M 7.53M 7.25M 6.88M 6.19M 5.18M 4.25M 3.21M 2.31M
Other Working Capital
-1.2M -875K -2.81M -9.49M -13.41M -15.64M -18.8M -18.88M -15.87M -17.44M -14.56M -30.2M -33.9M -35.57M -33.66M -12.51M -10.1M -8M
Other Non-Cash Items
-370K 2.83M 5.98M 11.98M 12.2M 10.54M 6.86M 899K 799K 971K 1.52M 1.55M 2.04M 1.25M 1.17M 12.26M 12.1M 12.15M
Deferred Income Tax
n/a n/a n/a -4.25M -4.83M -5.42M -5.42M -1.17M -597K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.8M -1.98M -3.98M -11.9M -16.62M -19.34M -21.67M -21.19M -18.68M -17.36M -15.14M -27.45M -30.54M -33.71M -33.03M -13.45M -10.27M -8.86M
Operating Cash Flow
-29.18M -38.26M -46M -61.56M -72.62M -78.26M -79.74M -75.58M -72.8M -74.11M -74.11M -69.82M -70.59M -66.87M -60.25M -59.45M -49.13M -41.12M
Capital Expenditures
n/a n/a n/a -262K -262K -266K -418K -387K -1.52M -1.55M -1.43M -1.75M -803K -954K -1.76M -1.86M -1.68M -1.49M
Cash Acquisitions
-245K -60K n/a -4K 241K 60K n/a -10.73M -47.64M -68.17M -68.17M -57.44M -20.52M n/a n/a 3.69M 3.69M 3.69M
Purchase of Investments
-39.22M -43.19M -88.3M -105.87M -115.27M -110.62M -90.05M -91.69M -88.39M -92.05M -216.34M -189.86M -175M -166.02M n/a n/a n/a n/a
Sales Maturities Of Investments
104.33M 72.08M 60.46M 90.71M 122.74M 137.04M 154.61M 146.34M 148.06M 149.56M 118.48M 81.28M 29.5M n/a n/a n/a n/a n/a
Other Investing Acitivies
-22.07M -6.88M -55.62M -27.48M 3.98M 3.8M 52.54M 42.63M 47.65M 68.17M -97.85M -110.36M -147.27M -167.79M -1.77M 3.69M 3.69M 3.69M
Investing Cash Flow
42.8M 21.77M -34.9M -14.99M 7.45M 26.21M 64.14M 54.27M 58.16M 55.96M -99.28M -110.33M -146.3M -166.97M -1.76M 1.83M 2.01M 2.2M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 108K n/a -663K -663K -771K -663K n/a n/a n/a n/a -1.09M -1.09M -1.09M -1.09M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 60K 39.09M 76.09M 76.09M 76.03M 37.03M 600K 1.09M 1.33M 1.38M 835K 436K 116.36M 116.29M 116.26M
Financial Cash Flow
n/a n/a n/a 60K 38.98M 75.98M 75.98M 75.92M 37.03M 600K 1.09M 1.33M 1.38M -295K 131.74M 247.66M 247.6M 248.69M
Net Cash Flow
13.62M -16.5M -80.91M -76.49M -26.19M 23.93M 60.38M 54.61M 22.38M -17.55M -172.3M -178.82M -215.52M -234.13M 69.73M 190.04M 200.47M 209.77M
Free Cash Flow
-29.18M -38.26M -46M -61.83M -72.88M -78.53M -80.16M -75.97M -74.32M -75.66M -75.54M -71.57M -71.4M -67.82M -62.01M -61.31M -50.81M -42.61M